Tag: AI-driven drug discovery

In the labyrinthine world of drug discovery, the quest to develop new medications is a marathon marked by thousands of ...

Machine Learning Uncovers New Antibiotics to Combat Resistant Gonorrhea The relentless surge of antibiotic-resistant gonorrhea poses an escalating threat to ...

In a groundbreaking recognition that underscores the rapidly evolving confluence of artificial intelligence and biotechnology, Alex Zhavoronkov, Founder and CEO ...

In the rapidly evolving landscape of therapeutic antibody development, efficiency and precision remain paramount challenges. Antibodies, as cornerstone molecules in ...

In an ambitious leap forward for pharmaceutical science, researchers at the University of Virginia School of Medicine have unveiled a ...

Insilico Medicine Accelerates Oncology Innovation with Four Novel AI-Designed Programs Unveiled at AACR 2026 In a striking demonstration of the ...

In a groundbreaking publication poised to redefine the future of drug discovery, researchers from Insilico Medicine and Lilly have unveiled ...

In a groundbreaking alliance set to redefine therapeutic discoveries for gastroesophageal cancers, Insilico Medicine, an industry leader in AI-driven drug ...

In a groundbreaking announcement set to redefine the future of pharmaceutical innovation, Insilico Medicine and China Medical System Holdings Limited ...

In a groundbreaking development within the realm of anti-inflammatory therapeutics, Insilico Medicine, a clinical-stage pioneer harnessing the power of generative ...